Stay updated on Losmapimod in COVID: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Losmapimod in COVID: Safety & Efficacy Clinical Trial page.

Latest updates to the Losmapimod in COVID: Safety & Efficacy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows Revision: v3.4.2 added and the prior Revision: v3.4.1 removed, along with the old government funding notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedNotice added about a lapse in government funding and NIH operating status. Site version updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedUI text updates include glossary toggle options, capitalization/phrasing of QC-related labels, and a revision/version indicator. These changes affect display text only and do not modify study content, eligibility criteria, outcomes, or results.SummaryDifference0.3%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no substantive changes to study details, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page's Locations list was updated to add new sites across multiple states and countries, and several previously listed locations were removed.SummaryDifference1%

- Check85 days agoChange DetectedThe page footer now shows Revision: v3.3.2, replacing v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Losmapimod in COVID: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Losmapimod in COVID: Safety & Efficacy Clinical Trial page.